Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A transcription factor addiction imposed by an oncogene promoter sequence

ABSTRACT: A transcription factor addiction imposed by an oncogene promoter sequence

PROVIDER: PRJNA474222 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7249350.fastq.gz	Fastqsanger.gz
	SRR7249360.fastq.gz	Fastqsanger.gz
	SRR7249370.fastq.gz	Fastqsanger.gz
	SRR7249380.fastq.gz	Fastqsanger.gz
	SRR7249390.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 83

Similar Datasets

A transcription factor addiction imposed by an oncogene promoter sequence [RNA-seq]

Project description:A transcription factor addiction imposed by an oncogene promoter sequence [RNA-seq]

| PRJNA474224 | ENA

A transcription factor addiction imposed by an oncogene promoter sequence [ChIP-seq]

Project description:A transcription factor addiction imposed by an oncogene promoter sequence [ChIP-seq]

| PRJNA474225 | ENA

A transcription factor addiction imposed by an oncogene promoter sequence

Project description:This SuperSeries is composed of the SubSeries listed below.

2018-10-26 | GSE115238 | GEO

Mechanism of Oncogene Addiction

Project description:Mechanism of Oncogene Addiction

| PRJNA302297 | ENA

A transcription factor addiction imposed by an oncogene promoter sequence [RNA-seq]

Project description:Transcriptome analysis by high throughput sequencing

2018-10-26 | GSE115237 | GEO

A transcription factor addiction imposed by an oncogene promoter sequence [ChIP-seq]

Project description:Genome-wide binding/occupancy profiling by high throughput sequencing

2018-10-26 | GSE115236 | GEO

An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies

Project description:Oncogene addiction provides important therapeutic opportunities for precision oncology treatment strategies. To date the cellular circuitries associated with driving oncoproteins, which eventually establish the phenotypic manifestation of oncogene addiction remain largely unexplored. We employed a targeted mass spectrometry approach to systematically explore alterations in 116 phosphosites related to oncogene signaling and its intersection with the DDR following inhibition of the addicting oncogene alone or in combination with irradiation in MET-, EGFR-, ALK- or BRAF (V600)-positive cancer models and ex vivo non-small cell lung cancer patient organotypic cultures. We identified an ‘oncogene addiction phosphorylation signature’ (OAPS) consisting of 8 protein phosphorylations (ACLY S455, IF4B S422, IF4G1 S1231, LIMA1 S490, MYCN S62, NCBP1 S22, P3C2A S259 and TERF2 S365) that are significantly suppressed upon targeted oncogene inhibition solely in addicted cell line models and patient tissues. We show that the OAPS is present in patient tissues and the OAPS-derived score strongly correlates with the ex vivo responses to targeted treatments.

2023-03-11 | PXD037406 | Pride

A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence.

Project description:The Mixed Lineage Leukemia gene (MLL) is altered in leukemia by chromosomal translocations to produce oncoproteins composed of the MLL N-terminus fused to the C-terminus of a partner protein. Here, we used domain-focused CRISPR screening to identify ZFP64 as an essential transcription factor in MLL-rearranged leukemia. We show that the critical function of ZFP64 in leukemia is to maintain MLL expression via binding to the MLL promoter, which is the most enriched location of ZFP64 occupancy in the human genome. The specificity of ZFP64 for MLL is accounted for by an exceptional density of ZFP64 motifs embedded within the MLL promoter. These findings demonstrate how a sequence anomaly of an oncogene promoter can impose a transcriptional addiction in cancer.

| S-EPMC6554023 | biostudies-literature

The role of microRNA miR-17-92 in MYC oncogene addiction

Project description:miR-17-92 mediates the MYC oncogene addiction in a conditional mouse lymphoma model. To identify targets of miR-17-92 in this model, miR-17-92 was expressed in the conditional lymphoma cell lines using MSCV-puro. Both control and miR-17-92-expressing conditional lymphoma cell lines were treated with doxycycline (DOX) (20ng/ml) for 48 hours to shut off MYC expression.

2014-05-29 | E-GEOD-57507 | biostudies-arrayexpress

The role of microRNA miR-17-92 in MYC oncogene addiction

2014-05-29 | GSE57507 | GEO